These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26139381)

  • 1. Proteasome Accessory Factor C (pafC) Is a novel gene Involved in Mycobacterium Intrinsic Resistance to broad-spectrum antibiotics--Fluoroquinolones.
    Li Q; Xie L; Long Q; Mao J; Li H; Zhou M; Xie J
    Sci Rep; 2015 Jul; 5():11910. PubMed ID: 26139381
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Xu J; Chen Y; Mou X; Huang Y; Ma S; Zhang L; Zhang Y; Long Q; Ali MK; Xie J
    Future Microbiol; 2020 Apr; 15():413-426. PubMed ID: 32250176
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T; Drlica K
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Swaminath S; Paul A; Pradhan A; Sebastian J; Nair RR; Ajitkumar P
    Microbiology (Reading); 2020 Feb; 166(2):180-198. PubMed ID: 31746727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemistry. Protein that mimics DNA helps tuberculosis bacteria resist antibiotics.
    Ferber D
    Science; 2005 Jun; 308(5727):1393. PubMed ID: 15933168
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of a Mycobacterium smegmatis transposon mutant array for characterising the mechanism of action of tuberculosis drugs: Findings with isoniazid and its structural analogues.
    Campen RL; Ackerley DF; Cook GM; O'Toole RF
    Tuberculosis (Edinb); 2015 Jul; 95(4):432-9. PubMed ID: 25936537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
    Maus CE; Plikaytis BB; Shinnick TM
    Antimicrob Agents Chemother; 2005 Feb; 49(2):571-7. PubMed ID: 15673735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Establishment and drug susceptibility test of isoniazid resistant Mycobacterium smegmatis].
    Jia PP; Zhao LL; Li XY; Zhang Q; Liu ZL; Wang X; Yu LY; Zhao LX; Cen S
    Yao Xue Xue Bao; 2011 Apr; 46(4):377-82. PubMed ID: 21751489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of Holliday junction resolvase in fluoroquinolone-mediated killing of Mycobacterium smegmatis.
    Long Q; Du Q; Fu T; Drlica K; Zhao X; Xie J
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1782-5. PubMed ID: 25534729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Mycobacterium tuberculosis NLPC/p60 family protein Rv0024 induce biofilm formation and resistance against cell wall acting anti-tuberculosis drugs in Mycobacterium smegmatis.
    Padhi A; Naik SK; Sengupta S; Ganguli G; Sonawane A
    Microbes Infect; 2016 Apr; 18(4):224-36. PubMed ID: 26706821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The K+ uptake regulator TrkA controls membrane potential, pH homeostasis and multidrug susceptibility in Mycobacterium smegmatis.
    Castañeda-García A; Do TT; Blázquez J
    J Antimicrob Chemother; 2011 Jul; 66(7):1489-98. PubMed ID: 21613307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of porins for uptake of antibiotics by Mycobacterium smegmatis.
    Danilchanka O; Pavlenok M; Niederweis M
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3127-34. PubMed ID: 18559650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique Mode of Cell Division by the Mycobacterial Genetic Resister Clones Emerging
    Jakkala K; Paul A; Pradhan A; Nair RR; Sharan D; Swaminath S; Ajitkumar P
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33208519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new dehydratase conferring innate resistance to thiacetazone and intra-amoebal survival of Mycobacterium smegmatis.
    Carrère-Kremer S; Blaise M; Singh VK; Alibaud L; Tuaillon E; Halloum I; van de Weerd R; Guérardel Y; Drancourt M; Takiff H; Geurtsen J; Kremer L
    Mol Microbiol; 2015 Jun; 96(5):1085-102. PubMed ID: 25754266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivities of ciprofloxacin-resistant Mycobacterium tuberculosis clinical isolates to fluoroquinolones: role of mutant DNA gyrase subunits in drug resistance.
    Suzuki Y; Nakajima C; Tamaru A; Kim H; Matsuba T; Saito H
    Int J Antimicrob Agents; 2012 May; 39(5):435-9. PubMed ID: 22421328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-Alanine specifically potentiates fluoroquinolone efficacy against Mycobacterium persisters via increased intracellular reactive oxygen species.
    Zhen J; Yan S; Li Y; Ruan C; Li Y; Li X; Zhao X; Lv X; Ge Y; Moure UAE; Xie J
    Appl Microbiol Biotechnol; 2020 Mar; 104(5):2137-2147. PubMed ID: 31940082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sigma factor F regulates Mycobacterium smegmatis hydrogen peroxide resistance].
    Wu H; Hu X; Xiao J; Zhang J; Tao J; Huang H; Mi K
    Wei Sheng Wu Xue Bao; 2012 Nov; 52(11):1352-9. PubMed ID: 23383506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimycobacterial activities of novel fluoroquinolones.
    Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V; Sriram D
    Biomed Pharmacother; 2009 Jan; 63(1):27-35. PubMed ID: 18031974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model.
    Cremades R; Rodríguez JC; García-Pachón E; Galiana A; Ruiz-García M; López P; Royo G
    J Antimicrob Chemother; 2011 Oct; 66(10):2281-3. PubMed ID: 21733966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knocking out salicylate biosynthesis genes in Mycobacterium smegmatis induces hypersensitivity to p-aminosalicylate (PAS).
    Nagachar N; Ratledge C
    FEMS Microbiol Lett; 2010 Oct; 311(2):193-9. PubMed ID: 20735479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.